Ken Griffin acquired 1.84 Million Twist Bioscience shares worth $52.6 Million. That's 0.05% of their equity portfolio (432nd largest holding). The investor owns 2.78% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q3 2019. Since then Ken Griffin bought shares eleven more times and sold shares on five occasions. The investor's estimated purchase price is $57.9 Million, resulting in a loss of 9.2%.